Accessory Function of Alveolar Macrophages from Patients with Sarcoidosis and Other Granulomatous and Nongranulomatous Lung Diseases

Journal of Investigative Medicine

Volumn 45, Issue 2, 1997, Pages 75-86

  Zissel, Gernot ^a   Ernst, Martin ^a   Schlaak, Max ^a   Müller Quernheim, Joachim ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Adhesion molecule; Alveolar macrophage; Lung disease; Sarcoidosis

Indexed keywords

B7 ANTIGEN; INTERLEUKIN 2;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MONOCYTE; SARCOIDOSIS; SECOND MESSENGER; T LYMPHOCYTE;

ADULT; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-2; LUNG DISEASES, INTERSTITIAL; LUNG DISEASES, OBSTRUCTIVE; LYMPHOCYTE ACTIVATION; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; MONOCYTES; SARCOIDOSIS, PULMONARY; SECOND MESSENGER SYSTEMS; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

EID: 0031062451     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Hunninghake GW, Fulmer JD, Young RC, Gadek JE, Crystal RG. Localisation of the immune response in sarcoidosis. Am Rev Respir Dis 1979;120:49-57.
2. Rosen Y, Athanassiades TJ, Moon S, Lyons HA. Nongranulomatous interstitial pneumonitis in sarcoidosis: relationship to development of epitheloid granulomas. Chest 1978;74:122-5.
3. Toews GB, Vial WC, Dunn MM, Guzetta P, Nunez G, Stastny P, Lipscomp MF. The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol 1984;132:181-6.
4. Ferro TF, Kern JA, Elias JA, Kamoun M, Daniele RP, Rossman MD. Alveolar macrophages, blood monocytes and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen. Am Rev Respir Dis 1987;135:682-7.
5. Chelen CJ, Fang Y, Freeman GJ, Secrist H, Marshall JD, Hwang PT, Frankel LR, DeKruyff RH, Umetsu DT. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995;95:1415-21.
6. Weissler JC, Mendelson C, Moya F, Yarbrough WCJ. Effect of interstitial lung disease macrophages on T-cell signal transduction. Am J Respir Crit Care Med 1994;149:191-6.
7. Yarbrough WCJ, Wilkes DS, Weissler JC. Inhibition of lymphokine-activated killer cells by human pulmonary macrophages: discordance between up-regulation of the beta chain (p75) of the interleukin-2 receptor on CD56+ cells and limited response to interleukin-2. Am J Respir Cell Mol Biol 1994;10:184-91.
8. Fireman E, Ben-Effraim S, Spinrad S, Topilsky M, Greif J, Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell to cell contact. Eur Respir J 1993;6 :956-64.
9. Ina Y, Takada K, Yamamoto M, Morishita M, Miyashi A. Antigen presenting capacity in patients with sarcoidosis. Chest 1990;98:911-6.
10. Lem VM, Lipscomb MF, Weissler JC, Nunez G, Ball EJ, Stastny P, Toews GB. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J Immunol 1985;135:1766-71.
11. Venet A, Hance A, Saltini C, Robinson BWS, Crystal RG. Enhanced alveolar macrophage-mediated antigen-induced T lymphocyte proliferation in sarcoidosis. J Clin Invest 1985;75:293-301.
12. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-8.
13. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
14. Hance AJ. Accessory-cell-lymphocyte interactions. In: Crystal RG, West JB, Barnes PJ, Cherniack NS, Weibel ER, eds. The lung: scientific foundations. New York: Raven Press, Ltd, 1991: 483-98.
15. Fraser JD, Straus D, Weiss A. Signal transduction events leading to T-cell lymphokine expression. Immunol Today 1993;14:357-62.
16. Striz I, Wang Y-M, Kalaycioglu O, Costabel U. Expression of alveolar macrophage adhesion molecules in pulmonary sarcoidosis. Chest 1992;102:882-6.
17. Schaberg T, Rau M, Stephan H, Lode H. Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells. Am Rev Respir Dis 1993;147:1507-13.
18. Zissel G, Aulitzky WE, Lorenz J, Huber, Müller-Quernheim J. Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2. Cancer Immunol Immunother 1996;42:122-6.
19. Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Floerchinger C, Helmers R, Merchant R, Wilson J, Galvin J, Schwartz D. Outcome of the treatment of sarcoidosis. Am J Respir Crit Care Med 1994;149:893-8.
20. Roosnek EE, Brouwer MC, Aarden LA. T cell triggering by lectins I. Requirements for interleukin-2 production: lectin concentration determines the accessory cell dependency. Eur J Immunol 1985;15:652-6.
21. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-34.
22. Bøyum A. Isolation of human blood monocytes with Nycodenz, a new nonionic iodinated gradient medium. Scand J Immunol 1983;17:429-36.
23. Gillis S, Ferm MM, Ou W, Smith KA. T-cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 1978;120:2027-32.
24. Farrar JJ, Mizel SB, Fuller-Farrar J, Farrar WL, Hilfiker ML. Macrophage-independent activation of helper T cells I. Production of interleukin-2. J Immunol 1980;125:793-8.
25. Müller-Quernheim J, Pfeiffer S, Männel D, Strausz J, Ferlinz R. Lung restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992;145:187-92.
26. Zissel G, Homolka J, Schlaak J, Schlaak M, Müller-Quernheim J. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Respir Crit Care Med 1996;154:713-9
27. Lecossier D, Valeyre D, Loiseau A, Cadranel J, Tazi A, Battesti J-P, Hance AJ. Antigen induced proliferative response of lavage and blood T lymphocytes. Am Rev Respir Dis 1991;144:861-8.
28. Nemoz G, Prigent AF, Aloui R, Charpin G, Gormand F, Gallet H, Desbos A, Biot N, Perrin-Fayolle M, Lagarde M, Pacheco Y. Impaired G-proteins and cyclic nucleotide phosphodiesterase activity in T lymphocytes from patients with sarcoidosis. Eur J Clin Invest 1993;23:18-27.
29. Klein JT, Horn TD, Forman JD, Silver RP, Teirstein AS, Moller DR. Selection of oligoclonal Vβ-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 1995;154:1450-60.
30. Müller-Quernheim J, Pfeiffer S, Strausz J, Ferlinz R. Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis. Am Rev Respir Dis 1991;144:1322.
31. Crystal RG, Hunninghake GW, Gadek JE, Keogh BA, Rennard SI, Bitterman PB. The pathogenesis of sarcoidosis. In: Chretien J, Marsac J, Saltiel JC. eds. Proceeds from the International Conference on Sarcoidosis and Other Granulomatous Disorders; 1981 Aug 31 to Sept 4; Paris. Oxford (UK) Peragamon Press, 1983: 13-35.
32. Kaltreider HB, Byrd PK, Curtis JL. Expression of Ia by murine alveolar macrophages is upregulated during the evolution of a specific immune response in pulmonary parenchyma. Am Rev Respir Dis 1988;137:1411-6
33. Melis M, Gjomarkaj M, Pace E, Malizia G, Spatafora M. Increased expression of leukocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) by alveolar macrophages of patients with pulmonary sarcoidosis. Chest 1991;100:910-6.
34. Costello R, Cerdan C, Pavon C, Brailly H, Hurpin C, Mawas C, Olive D. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells. Eur J Immunol 1993;23:608-13.
35. Fraser JD, Newton ME, Weiss A. CD 28 and T-cell antigen receptor signal transduction coordinately regulate interleukin-2 gene expression in response to superantigen stimulation. J Exp Med 1992;175:1131-4.
36. Liu Y, Jones B, Brady W, Janeway CA, Linley PS. Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen. Eur J Immunol 1992;22:2855-9.
37. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA, Lombard LA, Gray GS, Nadler LM. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates T cell proliferation Science 1993;262:909-11.
38. Lenschow DJ, Sperling AI, Cooke MP, Freeman G, Rhee L, Decker DC, Gray G, Nadler LM, Goodnow CC, Bluestone JA. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol 1994;153:1990-7.
39. Yamaguchi E, Okazaki N, Tsuneta Y, Abe S, Terai T, Kawakami Y. Interleukins in pulmonary sarcoidosis: dissociative correlations of lung interleukins-1 and 2 with the intensity of alveolitis. Am Rev Respir Dis 1988;138:645-51.
40. Müller-Quernheim J, Saltini C, Sondermeyer P, Crystal RG. Compartmentalized activation of the interleukin-2 gene by lung T-lymphocytes in active pulmonary sarcoidosis. J Immunol 1986;137:3475-83.
41. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T-lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983;308:793-800.
42. Gimmi CD, Freeman GJ, Gribben JG, Sugita K, Freeman AS, Morimoto C, Nadler LM. B cell surface antigen B7 provide a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 1991;88:6575-9.
43. Paine RI, Mody CH, Chawis A, Spahr MA, Turka LA, Toews GB. Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation. Am J Respir Cell Mol Biol 1991;5:221-9.
44. Kubin M, Kamoun M, Trinchieri G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 1994;180:211-22.
45. Robinson BWS, McLemore T, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T-lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985;75:1488-95.
46. Hoshino T, Itoh K, Gouhara R, Yamada A, Tanaka Y, Ichikawa Y, Azuma M, Mochizuki M, Oizumi K. Spontaneous production of varius cytokines except IL-4 from CD4+ T cells in the affected organs of sarcoidosis patients. Clin Exp Immunol 1995;102:399-405.
47. Khomenko I, Zissel G, Schlaak M, Müller-Quernheim J. Predominance of Th0-like cytokine pattern in blood and lung biopsy T-cell clones of patients with pulmonary sarcoidosis. Eur Respir J 1995;8:32S.
48. Racke MK, Scott DE, Quigley L, Gray GS, Abe R, June CH, Perrin PJ. Distinct roles for B7-1 (CD-80) and B7-2 (CD-81) in the inhibition of experimental allergic encephalomyelitis. J Clin Invest 1995;96:2195-203.
49. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH. B7-1 and B7-2 costimulatory molecules activate differentially the developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-18.
50. Chang TL, Shea CM, Urioste S, Tompson RC, Boom WH, Abbas AK. Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2 and IL4-producing (Th1 and Th2) clones to antigens presented by different accessory cells. J Immunol 1990;145:2803-8.
51. Schmitz J, Assenmacher M, Radbruch A. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur J Immunol 1993;23:191-9.
52. Gajewski TF, Pinnas M, Wong T, Fitch FW. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol 1991;146:1750-8.
53. Bucy RP, Panoskaltsis-Mortari A, Huang G-Q, Li J, Karr L, Ross M, Russell JH, Murphy KM, Weaver CT. Heterogeneity of single cell cytokine gene expression in clonal T cell populations. J Exp Med 1994;180:1251-62.
54. King CL, Stupi RJ, Craighead N, June CH, Thyphronitis G. CD28 activation promotes Th2 subset differentiation by human CD4+ cells. Eur J Immunol 1995;25:587-95.
55. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA. CD28-B7 blockade after allogenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995;181:1869-74.
56. Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991;5:171-7.
57. Schmitt E, Höhn P, Hüls C, Gödert S, Palm N, Rüde E, Germann T. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur J Immunol 1994;24:793-8.
58. Rook GAW, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones, and regulation of the Th1/Th2 balance. Immunol Today 1994;15:301-3.
59. Ayanlar Batuman O, Ferrero AP, Diaz A, Jimenez SA. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest 1991;88: 1574-80.
60. Haanen JBAG, de Waal Malefyt R, Res PCM, Kraakman EM, Ottenhoff THM, de Vries RRP, Spits H. Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 1991;174:583-92.
61. Robinson DS, Ying S, Taylor IK, Wangoo A, Mitchell DM, Kay AB, Hamid Q, Shaw RJ. Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am J Respir Crit Care Med 1994;149:989-93.
62. Fei R, Gott K, Edwards B, Schuyler M. Experimental hypersensitivity pneumonitis: in vitro effects of interleukin-2 and interferon-gamma. J Lab Clin Med 1995;126:485-94.
63. Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, Hansel TT, Villiger B. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Cnt Care Med 1994;150:1038-48.